HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph M Herman Selected Research

Phosphorus-32

1/2020An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol.
5/2019Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience.
1/2015Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph M Herman Research Topics

Disease

86Neoplasms (Cancer)
11/2022 - 07/2004
73Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 07/2009
64Adenocarcinoma
11/2022 - 01/2008
20Neoplasm Metastasis (Metastasis)
12/2017 - 12/2007
9Rectal Neoplasms (Rectal Cancer)
12/2019 - 01/2012
8Carcinoma (Carcinomatosis)
01/2018 - 07/2004
7Hepatocellular Carcinoma (Hepatoma)
01/2021 - 04/2012
5Liver Neoplasms (Liver Cancer)
01/2019 - 07/2013
4Disease Progression
01/2022 - 01/2016
4Lymphopenia (Lymphocytopenia)
12/2021 - 06/2015
3Nausea
11/2020 - 07/2012
3Stomach Neoplasms (Stomach Cancer)
05/2020 - 10/2014
3Fatigue
11/2019 - 12/2010
3Cholangiocarcinoma
10/2018 - 10/2013
3Pain (Aches)
08/2018 - 07/2003
3Prostatic Neoplasms (Prostate Cancer)
07/2013 - 10/2012
2Blister (Bulla)
06/2021 - 11/2020
2Thrombosis (Thrombus)
01/2021 - 06/2017
2Vomiting
11/2019 - 07/2012
2Margins of Excision
01/2018 - 02/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2017 - 07/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 05/2013
2Peritoneal Neoplasms
01/2017 - 01/2015
2Adenosquamous Carcinoma
04/2015 - 01/2010
2Hypoxia (Hypoxemia)
12/2014 - 04/2011
2Klatskin Tumor
08/2014 - 08/2012
2Liver Diseases (Liver Disease)
07/2013 - 02/2013
2Anus Neoplasms (Anal Cancer)
05/2013 - 08/2010
2Weight Loss (Weight Reduction)
07/2012 - 07/2010
2Sarcoma (Soft Tissue Sarcoma)
06/2008 - 07/2007
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2021
1Splenic Diseases
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Pelvic Neoplasms
07/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2020
1COVID-19
05/2020
1Circulating Neoplastic Cells
01/2019
1Arthritis (Polyarthritis)
01/2019
1Hemorrhage
08/2018
1Dermatitis
08/2018
1Dehydration (Water Stress)
08/2018

Drug/Important Bio-Agent (IBA)

16GemcitabineFDA Link
11/2022 - 07/2004
9Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 07/2008
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 08/2013
7AntigensIBA
01/2021 - 01/2014
7Biological ProductsIBA
03/2018 - 08/2006
5DNA (Deoxyribonucleic Acid)IBA
11/2022 - 07/2009
5Leucovorin (Folinic Acid)FDA Link
01/2022 - 01/2016
5Biomarkers (Surrogate Marker)IBA
01/2018 - 05/2014
5folfirinoxIBA
11/2017 - 06/2015
4HydrogelsIBA
06/2021 - 12/2017
4CarbohydratesIBA
01/2021 - 01/2014
4Irinotecan (Camptosar)FDA LinkGeneric
11/2017 - 01/2016
4Proteins (Proteins, Gene)FDA Link
01/2016 - 07/2009
3Phosphorus-32IBA
01/2020 - 01/2015
3veliparibIBA
01/2017 - 05/2014
3Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2013 - 12/2010
2Protons (Proton)IBA
01/2021 - 03/2018
2RadiumIBA
01/2021 - 12/2019
2130-nm albumin-bound paclitaxelIBA
01/2020 - 01/2016
2Pharmaceutical PreparationsIBA
01/2019 - 01/2015
2Albumin-Bound PaclitaxelFDA Link
01/2017 - 01/2016
2Molecular Chaperones (Chaperone, Molecular)IBA
01/2016 - 04/2013
2geldanamycinIBA
01/2016 - 04/2013
2Yttrium-90IBA
01/2016 - 03/2009
2Capecitabine (Xeloda)FDA Link
01/2016 - 12/2010
1Programmed Cell Death 1 ReceptorIBA
06/2022
1VaccinesIBA
01/2021
1Leflunomide (Arava)FDA LinkGeneric
01/2019
1Cell-Free Nucleic AcidsIBA
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1Insulin-Like Growth Factor Binding Protein 2IBA
01/2018

Therapy/Procedure

90Radiotherapy
11/2022 - 07/2004
58Therapeutics
11/2022 - 07/2004
31Drug Therapy (Chemotherapy)
11/2022 - 03/2009
19Neoadjuvant Therapy
05/2022 - 10/2012
16Pancreaticoduodenectomy
11/2017 - 07/2008
11Pancreatectomy
01/2022 - 01/2008
6Adjuvant Chemotherapy
01/2021 - 07/2008
6Brachytherapy
01/2020 - 01/2012
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
08/2018 - 01/2012
4Chemoradiotherapy
01/2017 - 01/2012
4Aftercare (After-Treatment)
01/2016 - 09/2007
3Induction Chemotherapy
02/2022 - 08/2015
3Proton Therapy
01/2021 - 01/2019
3Re-Irradiation
07/2020 - 12/2013
3Adjuvant Chemoradiotherapy
01/2018 - 07/2008
3Lymph Node Excision (Lymph Node Dissection)
08/2015 - 06/2012
2Injections
06/2021 - 11/2020
2Image-Guided Radiotherapy
11/2020 - 05/2017
2Heavy Ion Radiotherapy
03/2018 - 01/2017
2Maintenance Chemotherapy
01/2018 - 12/2013
2Proctectomy
05/2016 - 10/2015
2Hepatectomy
02/2014 - 08/2012
2Liver Transplantation
08/2012 - 04/2012
2Stents
07/2012 - 02/2010
2Palliative Care (Palliative Therapy)
11/2011 - 03/2009
1Immunotherapy
01/2021
1Ostomy
08/2018
1Highly Active Antiretroviral Therapy (HAART)
01/2018